Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27311969)

Published in Biol Blood Marrow Transplant on June 14, 2016

Authors

Solomon A Graf1, Jennifer E Vaughn2, Thomas R Chauncey1, Barry E Storer3, Ajay K Gopal4, Leona A Holmberg4, Jeannine S McCune5, William I Bensinger4, David G Maloney4, Oliver W Press4, Rainer Storb4, Mohamed L Sorror6

Author Affiliations

1: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington; Veterans Affairs Puget Sound Health Care System, Seattle, Washington.
2: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington; Department of Medicine, Blue Ridge Cancer Care, Virginia Tech Carilion School of Medicine, Roanoke, Virginia.
3: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Biostatistics, University of Washington, Seattle, Washington.
4: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.
5: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Pharmacy, University of Washington, Seattle, Washington.
6: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address: msorror@fredhutch.org.

Articles cited by this

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med (1999) 22.81

Revised response criteria for malignant lymphoma. J Clin Oncol (2007) 22.19

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull (1968) 20.58

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood (2005) 10.63

Regression modelling strategies for improved prognostic prediction. Stat Med (1984) 7.09

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol (2010) 5.20

Alcohol screening scores and medication nonadherence. Ann Intern Med (2008) 1.94

Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol (2002) 1.55

How I assess comorbidities before hematopoietic cell transplantation. Blood (2013) 1.52

Classification of alcohol use disorders. Alcohol Res Health (2003) 1.31

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation. Leukemia (2009) 1.30

Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma. Biol Blood Marrow Transplant (2008) 1.15

Focus on: Alcohol and the immune system. Alcohol Res Health (2010) 1.11

Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant (2006) 1.07

Alcohol-use disorders in the critically ill patient. Chest (2010) 1.07

Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry. Haematologica (2008) 1.04

Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2009) 0.99

Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older. Bone Marrow Transplant (2001) 0.97

Psychosocial factors and hematopoietic stem cell transplantation: potential biobehavioral pathways. Psychoneuroendocrinology (2013) 0.94

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. Biol Blood Marrow Transplant (2015) 0.93

Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adults. Int J Behav Med (2014) 0.90

A systematic review of psychosocial factors affecting survival after bone marrow transplantation. Psychosomatics (2003) 0.88

Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses. Alcohol (2011) 0.87

Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. Biol Blood Marrow Transplant (2013) 0.86

Peri-transplant psychosocial factors and neutrophil recovery following hematopoietic stem cell transplantation. PLoS One (2014) 0.85

Alcohol screening scores and 90-day outcomes in patients with acute lung injury. Crit Care Med (2013) 0.84

Is there an upper age limit for bone marrow transplantation? Bone Marrow Transplant (2002) 0.84

Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma. Biol Blood Marrow Transplant (2014) 0.84

Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study. Bone Marrow Transplant (2014) 0.82

Chemotherapy treatment decision making by professionals and older patients with cancer: a narrative review of the literature. Eur J Cancer Care (Engl) (2011) 0.80

Psychological risk factors and early complications after bone marrow transplantation in adults. Bone Marrow Transplant (1999) 0.80

High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study. Biol Blood Marrow Transplant (2014) 0.79

Substance abuse and bone marrow transplant. Am J Drug Alcohol Abuse (1997) 0.79

The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma. Bone Marrow Transplant (2014) 0.77